(1)
Overview of the Advantages and Disadvantages of Chimeric Antigen Receptor T Cell Therapy in the Tumor Microenvironment. Biomed. Res. Ther. 2022, 9 (10), 5341-5350. https://doi.org/10.15419/bmrat.v9i10.772.